로딩 중…
지수 로딩 중…
Aura Biosciences, Inc.
AURA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.15+1.56%
2026-08-04
Financials
Valuation Metrics
Aura Biosciences, Inc.'s Market Cap is $739M. At end of 2025 it was $359M. Ranked #2644 of 3,112 in US market (top 85%), #1117 of 1,445 on NASDAQ (top 77%), #206 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 77%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $739M | US#2,644/3,112 Sec#206/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-112M | US—/3,112 Sec—/269 |
| Total Assets | $138M | US#3,014/3,112 Sec#258/269 |
| Net Assets | $107M | US#2,874/3,112 Sec#228/269 |
| Value | ||
| P/B | 6.89x | US#2,396/3,112 Sec#170/269 |
| FCF Yield | -12.40% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -104.80% | US#2,853/3,112 Sec#221/269 |
| ROA | -81.64% | US#3,033/3,112 Sec#256/269 |
| Financial Health | ||
| Debt Ratio | 28.37% | US#308/3,112 Sec#103/269 |
| Total Debt | $17M | US#2,720/3,112 Sec#187/269 |
| FCF | $-92M | US#2,575/3,112 Sec#147/269 |
| Cash | $85M | US#2,309/3,112 Sec#187/269 |
| Current Ratio | 7.09x | US#336/3,112 Sec#110/269 |
| Performance | ||
| 1Y Return | 8.17% | US#1,876/3,112 Sec#184/269 |
| 1M Return | -7.62% | US#2,545/3,112 Sec#157/269 |
| From 52W High | -25.05% | US#1,998/3,112 Sec#142/269 |
| 1Y MDD | -31.26% | US#1,471/3,112 Sec#93/269 |
| Trading | ||
| Volume | 250,942 shares | US#2,197/3,112 Sec#216/269 |
| Trading Value | $2M | US#2,834/3,112 Sec#236/269 |
| Per Share | ||
| EPS | $-1.22 | US—/3,112 Sec—/269 |
| BPS | $2.38 | US#2,472/3,112 Sec#168/269 |